The molecular mechanisms controlling the pathological symptoms of VWM can be investigated by identifying changes in protein expression caused by mutations in EIF2B. In some previous studies, proteomics approaches were used to investigate the molecular mechanisms affecting VWM [6,7,8]. Here, EIF2B4 is linked to leukoencephalopathy with vanishing white matter.